PubMed COVID-19 Clinical Care
4871 - 4880 of 7311 results found
COVID-19 infection in people living with HIV
Description
BACKGROUND: Coronavirus disease 2019 (COVID-19) and human immunodeficiency virus (HIV) are intersecting pandemics, with implications for care at an individual and global scale.
Clinical, Imaging, and Histopathological Features of Pulmonary Sequelae Following Mild COVID-19
Description
No abstract
COVID-19 as a factor associated with early dental implant failures: A retrospective analysis
Description
CONCLUSIONS: COVID-19 had no significant effect on early implant failure. Smoking and short implants were associated with a higher risk for early implant failures.
COVID-19 infection: a possible induction factor for development of autoimmune diseases?
Description
Following the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the importance of investigation of the pathogenesis and immunological characteristics of COVID-19 became quite clear. Currently, there are reports
Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19
Description
CONCLUSION: Our results suggest that use of PRN injections increased in LTC during the pandemic and contribute to the mounting evidence that agitation worsened during that time.
COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment
Description
PURPOSE OF REVIEW: This review aims to comprehensively explore the clinical characteristics of COVID-19-related cardiac injury and examine the potential mechanisms underlying cardiac injury in patients affected by COVID-19.
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
Description
Severe acute respiratory syndrome coronavirus 2-neutralizing antibodies primarily target the spike receptor binding domain (RBD). However, B cell antigen receptors (BCRs) on RBD-binding memory B (B(mem)) cells have variation in the neutralizing
CROI 2023: Acute and Post-Acute COVID-19
Description
Studies of acute and post-acute COVID-19 were presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). Early treatment with ensitrelvir, a novel protease inhibitor, hastened viral clearance and symptom resolution during
COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants
Description
Background: Although mass vaccination is considered one of the most effective public health strategies during the pandemic, in the COVID-19 era, many people considered vaccines unnecessary and, or doubted the effectiveness of the COVID-19 vaccine
